University of Florida McKnight Brain Institute received a $2.4 million National Institutes of Health grant to study regenerative process of the Mexican axolotl salamander with the aim of applying biological lessons learned to spinal cord injury.
TaiGen Biotechnology Reports Phase I and Preclinical Data for TG-0054 at the 2009 American Society of Hematology Meeting
The ability of TG-0054 to cause mobilization of EPC may support its use in other areas besides hematology. For instance the body may be able to grow new blood vessels around the areas of ischemia.
Dr. Jialiang Wang of Duke University reported that Notch signaling in tumor tissue is related to the failure of radiation treatments.
The New England Journal of Medicine reported a clinical trial at the Clinical Center of the National Institutes of Health in Bethesda, that described successful treatment of 9 out of 10 adults suffering from Sickle cell anemia.
From the medical journal PloS ONE, scientists from the University of California Los Angeles reported that human blood cells derived from adult stem cells can be engineered into cells that can target and kill HIV-infected cells.
Stem cells were created from the skin of patients with these diseases and then the stem cells were made into disease-specific neurons by treatment with growth factors.
Researchers presented data indicating that treatment of mice that suffer from corneal scarring with stem cells derived from human umbilical cords leads to preservation of vision.
The Cleveland Clinic has received a $2.75 million federal grant from the Department of Defense. The study will investigate patients with relapse-remitting MS that are still able to walk but have moderate to severe disability.
Doctors at the University of Texas Medical School at Houston have announced initiation of an efficacy-finding study in the area of heart failure using a "universal donor" stem cell product called "Prochymal".
In a recent news announcement, a case of a child in Singapore with cerebral palsy that was treated with their own cord blood stem cells was discussed.